Technical Analysis for CABA - Cabaletta Bio, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 11.01 | -9.61% | -1.17 |
CABA closed down 9.61 percent on Friday, April 26, 2024, on 2.85 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 9
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Lower Bollinger Band Walk | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Wide Bands | Range Expansion | -9.61% | |
Gapped Down | Weakness | -9.61% | |
Lower Bollinger Band Touch | Weakness | -9.61% | |
Oversold Stochastic | Weakness | -9.61% |
Alert | Time |
---|---|
Down 1 ATR | 2 days ago |
Fell Below Lower Bollinger Band | 2 days ago |
Down 5% | 2 days ago |
Fell Below Previous Day's Low | 2 days ago |
60 Minute Opening Range Breakdown | 3 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Immunology Antibodies Autoimmune Disease Autoimmunity T Cell Sjögren Syndrome
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Immunology Antibodies Autoimmune Disease Autoimmunity T Cell Sjögren Syndrome
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 26.35 |
52 Week Low | 9.02 |
Average Volume | 1,024,628 |
200-Day Moving Average | 17.27 |
50-Day Moving Average | 18.62 |
20-Day Moving Average | 15.51 |
10-Day Moving Average | 13.77 |
Average True Range | 1.13 |
RSI (14) | 18.70 |
ADX | 34.72 |
+DI | 10.72 |
-DI | 39.83 |
Chandelier Exit (Long, 3 ATRs) | 15.64 |
Chandelier Exit (Short, 3 ATRs) | 14.39 |
Upper Bollinger Bands | 19.82 |
Lower Bollinger Band | 11.20 |
Percent B (%b) | -0.02 |
BandWidth | 55.52 |
MACD Line | -1.80 |
MACD Signal Line | -1.44 |
MACD Histogram | -0.3635 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 12.98 | ||||
Resistance 3 (R3) | 13.19 | 12.74 | 12.65 | ||
Resistance 2 (R2) | 12.74 | 12.24 | 12.64 | 12.54 | |
Resistance 1 (R1) | 11.88 | 11.93 | 11.66 | 11.67 | 12.43 |
Pivot Point | 11.43 | 11.43 | 11.32 | 11.33 | 11.43 |
Support 1 (S1) | 10.57 | 10.93 | 10.35 | 10.36 | 9.59 |
Support 2 (S2) | 10.12 | 10.62 | 10.02 | 9.48 | |
Support 3 (S3) | 9.26 | 10.12 | 9.37 | ||
Support 4 (S4) | 9.05 |